Anti-staphylococcal responses and their relationship with HLA-DR-DQ polymorphism in granulomatosis with polyangiitis: a preliminary evidence of association with disease outcome

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Clinical and Experimental Medicine (Testo stampato)

• Publication date

  2022-07-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10238-022-00865-6PMID 35881260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ANCA-associated vasculitis

  2020cited by this paper
• Distinct HLA and non‐HLA associations in different subtypes of ANCA‐associated vasculitides in North India

  2020cited by this paper
• Management of ANCA associated vasculitis

  2020influential reference
• Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype

  2019cited by this paper
• Multiple sclerosis: disease modifying therapy and the human leukocyte antigen.

  2018cited by this paper
• Clinical features and long‐term outcomes of 105 granulomatosis with polyangiitis patients: A single center experience from north India

  2017cited by this paper
• Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

  2017cited by this paper
• Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study

  2016cited by this paper
• Targeting B-cell non Hodgkin lymphoma: New and old tricks.

  2016cited by this paper
• Clinical profile and long-term outcome of granulomatosis with polyangiitis (GPA): A corporate hospital-based study from northern India

  2015cited by this paper
• Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases

  2015influential reference
• Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure

  2015cited by this paper
• Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis.

  2015cited by this paper
• Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

  2015cited by this paper
• Characteristics of granulomatosis with polyangiitis patients in Japan

  2015cited by this paper
• Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis).

  2014cited by this paper
• Genetics of ANCA-associated vasculitides: HLA and beyond.

  2014cited by this paper
• MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity

  2013cited by this paper
• The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener’s): a retrospective study of 45 patients in Korea

  2013cited by this paper
• Genetically distinct subsets within ANCA-associated vasculitis.

  2012cited by this paper
• HLA molecules and nasal carriage of Staphylococcus aureus isolated from dialysis and kidney transplant patients at a hospital in Southern Brazil

  2012cited by this paper
• Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis

  2012cited by this paper
• Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

  2011cited by this paper
• Towards a systems understanding of MHC class I and MHC class II antigen presentation

  2011cited by this paper
• Staphylococcal Alpha-Toxin Is a Strong Inducer of Interleukin-17 in Humans

  2011cited by this paper
• Toll-like Receptors and Lupus Nephritis

  2011cited by this paper
• Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades.

  2011cited by this paper
• Severity of Staphylococcus aureus Infection of the Skin Is Associated with Inducibility of Human β-Defensin 3 but Not Human β-Defensin 2

  2010cited by this paper
• Levels of Antibody against 11 Staphylococcus aureus Antigens in a Healthy Population

  2010influential reference
• Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps.

  2010cited by this paper
• HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients.

  2009cited by this paper
• Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement

  2009cited by this paper
• Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary Wegener's granulomatosis.

  2008cited by this paper
• Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis.

  2007cited by this paper
• Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.

  2005cited by this paper
• Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.

  2003cited by this paper
• Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis

  2003cited by this paper
• An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

  2000cited by this paper
• Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin.

  1997cited by this paper
• Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu.

  1996cited by this paper
• Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

  1996cited by this paper
• Subunit stoichiometry of staphylococcal alpha-hemolysin in crystals and on membranes: a heptameric transmembrane pore.

  1994cited by this paper
• Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis

  1994cited by this paper
• Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation

  1994cited by this paper
• Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.

  1993cited by this paper
• Wegener Granulomatosis: An Analysis of 158 Patients

  1992cited by this paper
• The staphylococcal enterotoxins and their relatives.

  1990cited by this paper
• Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes

  1989cited by this paper
• Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin

  1987cited by this paper
• Clinicopathological profile of vasculitides in India.

  1985cited by this paper
• Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus.

  1983cited by this paper

• HLA sequencing identify novel associations and sugests clinical relevance of DPB1*04:01 in ANCA-associated granulomatosis with polyangiitis.

  2023cites this paper
• Study of HLA-A and HLA-DR Polymorphism in Local Population, Pakistan

  2023cites this paper
• Staphylococcus aureus adaptive evolution: Recent insights on how immune evasion, immunometabolic subversion and host genetics impact vaccine development

  2022cites this paper